Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.

Seminars in vascular medicine - 1 Aug 2004

Fouchier Sigrid W, Defesche Joep C, Kastelein John J P, Sijbrands Eric J G

Abstract excerpt

Patients with familial hypercholesterolemia (FH) or familial defective apolipoprotein B (FDB) have severely increased low-density lipoprotein (LDL)-cholesterol levels and increased risk for premature coronary artery disease (CAD). Previous data on FDB patients were collected in patients referred to lipid clinics and were therefore subject to referral bias. We assessed the clinical phenotype of FDB in a population...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoproteins B
Share to Cholesterol
Share to Coronary Artery Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hyperlipoproteinemia Type II

Share to Lipoproteins

Share to Mass Screening

Share to Netherlands

Share to Receptors, LDL

Source

Identifiers

PMID: 15630635
DOI: 10.1055/s-2004-861493

Genes

CAD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.PMID 15630635Read ↗

Evaluation of clinical diagnosis criteria of familial ligand defective apoB 100 and lipoprotein phenotype comparison between LDL receptor gene mutations affecting ligand-binding domain and the R3500Q mutation of the apoB gene in patients from a South European population.Semantic proximity Read ↗

Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia.Semantic proximity Read ↗

Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemia.Semantic proximity Read ↗

Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication.Semantic proximity Read ↗

Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia.Semantic proximity Read ↗

Familial defective apolipoprotein B-100: A review.Semantic proximity Read ↗

R3531C mutation in the apolipoprotein B gene is not sufficient to cause hypercholesterolemia.Semantic proximity Read ↗

Characterization of six patients who are double heterozygotes for familial hypercholesterolemia and familial defective apo B-100.Semantic proximity Read ↗

Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review.Semantic proximity Read ↗

Familial hypercholesterolemia and familial defective apolipoprotein B-100: comparison of the phenotypic expression In 116 cases.Semantic proximity Read ↗

A form of familial hypobetalipoproteinaemia not due to a mutation in the apolipoprotein B gene.Semantic proximity Read ↗

Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.